Clinical Trial Details

Trial ID: L0434
Source ID: IRCT20150819023685N2
Associated Drug: Folic acid
Title: Efficacy of folic acid in the treatment of non-alcoholic fatty liver in patients with hepatic fibrosis
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Nonalcoholic steatohepatitis. <br>Fatty (change of) liver, not elsewhere classified;K75.81
Interventions: Intervention 1: Intervention group: Folic acid tablet, 5 mg, oral, once a day, for 6 months. Intervention 2: Control group: placebo tablet, oral, once a day, for 6months.
Outcome Measures: Liver stiffness. Timepoint: At baseline and 24 weeks after the start of the intervention. Method of measurement: Fibroscan.Blood levels of liver enzymes. Timepoint: At baseline and 24 weeks after the start of the intervention. Method of measurement: Blood test.
Sponsor/Collaborators: Ghoum University of Medical Sciences
Gender: All
Age: 18 years65 years
Phases: Phase 3
Enrollment: 60
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants will be randomly assigned to the intervention or control group in the random blocks based on the random n
Start Date: 22/02/2020
Completion Date: --
Results First Posted: --
Last Update Posted: 24 March 2020
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/45681